Death or survival: Membrane ceramide controls the fate and activation of antigen-specific T-cells depending on signal strength and duration

作者: Cynthia Detre , Endre Kiss , Zoltán Varga , Katalin Ludányi , Katalin Pászty

DOI: 10.1016/J.CELLSIG.2005.05.012

关键词:

摘要: Abstract Sphingomyelinase (SMase)-mediated release of ceramide in the plasma membrane T-lymphocytes induced by different stimuli such as ligation Fas/CD95, irradiation, stress, inflammation or anticancer drugs primarily involves mitochondrial apoptosis signaling, but under specific conditions non-apoptotic Fas-signaling was also reported. Here we investigated, using a quantitative simulation model with exogenous C2-ceramide (and SMase), dependence activation and fate T-cells on strength duration accumulation. A murine, influenza virus hemagglutinin-specific T-helper cell (IP12-7) alone together interacting antigen presenting B-cells (APC) used. T H cells above ‘threshold’ stimulus (> 25 μM ‘strength’ > 30 min duration), while below threshold non-apoptotic, confirmed early late apoptotic markers (PS-translocation, depolarization, caspase-3 activation, DNA-fragmentation). The modest strongly suppressed calcium response inhibited several downstream signal events (e.g. ERK1/2-, JNK-phosphorylation, CD69 expression IL-2 production) during both anti-CD3 APC-triggered activation. Ceramide moderately affected Ca 2+ -release from internal stores upon antigen-specific engagement TCR immunological synapses, influx phase remarkably reduced amplitude rate, suggesting that major target(s) ceramide-effects are membrane-proximal. Kv1.3 potassium channels, store operated -entry (SOC) depolarized to which contribution spontaneously formed channels is possible. impaired function these transporters may be coupled quantitative, raft-remodeling effect responsible, concerted action, for Our results suggest Fas stimuli, received previously activated, FasL+ lymphocytes lymph nodes, negatively regulate subsequent T-cell thus modulate response.

参考文章(57)
M. M. Winslow, IMMUNOLOGY: Decoding Calcium Signaling Science. ,vol. 307, pp. 56- 57 ,(2005) , 10.1126/SCIENCE.1108163
G C Tsokos, B Kovacs, Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes. Journal of Immunology. ,vol. 155, pp. 5543- 5549 ,(1995)
Jayashree Aiyar, D. C. Hanson, K. G. Chandy, R. J. Mather, G. A. Gutman, S. Grissmer, D. D. Auperin, A. N. Nguyen, M. J. Karmilowicz, Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Molecular Pharmacology. ,vol. 45, pp. 1227- 1234 ,(1994)
Dieter Adam, Michael Heinrich, Dieter Kabelitz, Stefan Schütze, Ceramide: does it matter for T cells? Trends in Immunology. ,vol. 23, pp. 1- 4 ,(2002) , 10.1016/S1471-4906(01)02091-9
I. Nicoletti, G. Migliorati, M.C. Pagliacci, F. Grignani, C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry Journal of Immunological Methods. ,vol. 139, pp. 271- 279 ,(1991) , 10.1016/0022-1759(91)90198-O
Ildikò Szabò, Erich Gulbins, Horst Apfel, Xinfeng Zhang, Petra Barth, Andreas E. Busch, Klaus Schlottmann, Olaf Pongs, Florian Lang, Tyrosine Phosphorylation-dependent Suppression of a Voltage-gated K+Channel in T Lymphocytes upon Fas Stimulation Journal of Biological Chemistry. ,vol. 271, pp. 20465- 20469 ,(1996) , 10.1074/JBC.271.34.20465
Gordon Chan, Atsuo Ochi, Sphingomyelin-ceramide turnover in CD28 costimulatory signaling. European Journal of Immunology. ,vol. 25, pp. 1999- 2004 ,(1995) , 10.1002/EJI.1830250730
Erich Gulbins, Reid Bissonnette, Artin Mahboubi, Seamus Martin, Walter Nishloka, Thomas Brunner, Gottfried Baier, Gabriele Baler-Bltterlich, Cynthia Byrd, Florian Lang, Richard Kolesnick, Amnon Altman, Douglas Green, FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway Immunity. ,vol. 2, pp. 341- 351 ,(1995) , 10.1016/1074-7613(95)90142-6
Dagmar Scheel-Toellner, Mike Salmon, Janet M. Lord, A Life-Raft for Death Signalling? Cancer Biology & Therapy. ,vol. 2, pp. 396- 397 ,(2003) , 10.4161/CBT.2.4.455